NISA INVESTMENT ADVISORS, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$61,391
+214.6%
2,001
+310.9%
0.00%
Q2 2023$19,514
+51252.6%
487
-48.0%
0.00%
Q1 2023$38
-37.7%
936
-41.2%
0.00%
Q4 2022$61
-99.9%
1,591
+0.6%
0.00%
-100.0%
Q3 2022$82,000
-18.0%
1,582
-7.5%
0.00%0.0%
Q2 2022$100,000
-17.4%
1,711
+7.8%
0.00%0.0%
Q1 2022$121,000
+12.0%
1,587
-8.0%
0.00%0.0%
Q4 2021$108,000
-65.4%
1,725
-69.0%
0.00%
-50.0%
Q3 2021$312,000
+13.5%
5,571
+22.8%
0.00%0.0%
Q2 2021$275,000
-33.9%
4,538
-23.6%
0.00%
-33.3%
Q1 2021$416,000
+17.2%
5,9380.0%0.00%
+50.0%
Q4 2020$355,000
+171.0%
5,938
+173.0%
0.00%
+100.0%
Q3 2020$131,000
-89.3%
2,175
-90.7%
0.00%
-90.9%
Q2 2020$1,224,000
+369.0%
23,321
+199.4%
0.01%
+266.7%
Q1 2020$261,000
-23.0%
7,790
+4.0%
0.00%0.0%
Q4 2019$339,000
+23.7%
7,490
+4.2%
0.00%
+50.0%
Q3 2019$274,000
-18.7%
7,190
-7.2%
0.00%
-33.3%
Q2 2019$337,000
+14.2%
7,7480.0%0.00%0.0%
Q1 2019$295,000
+1866.7%
7,748
+2113.7%
0.00%
Q4 2018$15,000
-25.0%
350
-13.6%
0.00%
Q3 2018$20,000
+53.8%
4050.0%0.00%
Q2 2018$13,000
+160.0%
405
+131.4%
0.00%
Q1 2018$5,000
-64.3%
175
-56.2%
0.00%
Q3 2016$14,000
+7.7%
4000.0%0.00%
Q2 2016$13,000
-38.1%
4000.0%0.00%
Q1 2016$21,0004000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders